MEDICAL NEWS TODAY | DAILY NEWS
The FDA has proposed excluding weight-loss drugs, such as Ozempic/Wegovy and Zepbound from a key compounding list, potentially ‌limiting large-scale production by outsourcing facilities.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
FDA proposes ban on bulk compounding of semaglutide and tirzepatide
 
READ ON
→
Non-Hodgkin lymphoma and diet
 
READ ON
→
What is the link between Sjögren disease and NHL?
 
READ ON
→
 
 
 
 
 
What to know about non-small cell lung cancer (NSCLC)
 
 
ADHD: Why do women get missed out?
 
LISTEN ON Spotify   Listen on Apple Podcasts